A. Ashkenazi
Molecular Biology · 2000–2017
A researcher in the Science corpus: 9 papers; trusts 8 researchers and is trusted by 19 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 94 citations into it; #2,075 of 17,773 by trust here, #5,084 by citations
- Immunology — 35 citations into it; #158 of 2,160 by trust here, #1,250 by citations
- Cancer Research — 21 citations into it
Whom A. Ashkenazi trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts A. Ashkenazi overall
- Zhaoyu Jin
- Jerry M. Adams
- Stephen W. Fesik
- Bharat B. Aggarwal
- Alexandru Almasan
- Simone Fulda
- Yun Li
- D. Longley
- M. Smyth
- Ricky W. Johnstone
Papers from A. Ashkenazi's perspective
Ordered by how strongly the researchers A. Ashkenazi trusts endorse each paper. Same corpus, a different order for every researcher.
- The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. (Molecules and Cells)
- Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. (Cell)
- Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand (Nature Medicine)
- Promoting apoptosis as a strategy for cancer drug discovery (Nature Reviews. Cancer)
- Targeting death and decoy receptors of the tumour-necrosis factor superfamily (Nature Reviews. Cancer)
- Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. (Cell)
- The Bcl2 family: regulators of the cellular life-or-death switch (Nature Reviews. Cancer)
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy (Clinical Cancer Research)
- Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. (Immunity)
- The CD95(APO-1/Fas) DISC and beyond (Cell Death and Differentiation)
Their papers
- From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors (2017) — 819 citations
- Targeting death and decoy receptors of the tumour-necrosis factor superfamily (2002) — 1,433 citations
- Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. (2000) — 1,005 citations
- Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL (2007) — 617 citations
- Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. (2009) — 633 citations
- Pharmacological brake-release of mRNA translation enhances cognitive memory (2013) — 633 citations
- Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions (2001) — 757 citations
- Apo2L/TRAIL and its death and decoy receptors (2003) — 888 citations
- Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. (2003) — 595 citations